Zivo Bioscience, Inc. (ZIVO)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 53,400 | - | 31,500 | - |
| Product costs | 35,478 | - | 22,050 | - |
| Total cost of goods sold | 35,478 | - | 22,050 | - |
| Gross margin | 17,922 | - | 9,450 | - |
| Research and development | 479,657 | 2,769,236 | 326,361 | 2,252,325 |
| General and administrative | 1,171,137 | 1,439,552 | 1,943,127 | 5,977,277 |
| Total costs and expenses | 1,650,794 | 4,208,788 | 2,269,487 | 8,229,602 |
| Loss from operations | -1,632,872 | -4,208,788 | -2,260,037 | -8,229,602 |
| Interest expense | 7,360 | 2,400 | 8,560 | 6,766 |
| Amortization of debt discount | - | - | - | - |
| Total other expense | 7,360 | 2,400 | 8,560 | 6,766 |
| Net loss | -1,640,232 | -4,211,188 | -2,268,597 | -8,236,368 |
| Net loss | - | - | -2,268,597 | -8,236,368 |
| Basic & diluted average shares | - | - | - | 2,961,606 |
| Basic & diluted eps | - | - | -0.67 | -2.78 |
| Basic and diluted loss per share | -0.43 | -1.12 | - | - |
| Weighted average basic and diluted shares outstanding | 3,810,065 | 3,750,079 | - | - |